Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
NCT07768150Not yet recruiting
Randomised trial of dezocine in postoperative delirium (POD) (2 arms), sponsored by Chinese Academy of Medical Sciences. Primary endpoint: Incidence of postoperative delirium at 7 days. Planned start Sep 2026; status: not yet recruiting.
Beyond the preview
Study design, results and competitive context are available in the Gosset platform where reported.
Available in the Gosset platform where reported.
Available in the Gosset platform where reported.
See how Gosset can support your research on NCT07768150.